strain shows a number of interesting properties which may reflect the role of Nnt in a wildtype mouse, i.e., a glucose intolerance reflecting an insufficient insulin secretion, a several-fold higher sensitivity to MPTP, an agent that introduces a Parkinson's diseaselike condition, and a low frequency of spontaneous as well as chemically induced tumors. In addition, knockout of the mitochondrial superoxide dismutase (SOD2) in the C57BL/6J background produces mice with serious cardiac disease. Most of the above observations in the C57BL/6J mice can be explained by a decreased capacity for inactivating free radicals and preventing oxidative stress by GSH-linked reactions. The reason for the lowered cancer frequency is less obvious. It is proposed that Nnt, by being linked to the Δp, in addition to maintaining a high GSH, constitutes a sensing device for estimating the quality of the mitochondria and thus the host cell. A lowered Δp leads to a lower Nnt activity, a lower NADPH/NADP + ratio, a higher steady-state concentration of H 2 O 2 , and a higher rate of apoptosis. A lack of Nnt, as in the C57BL/6J mouse, thus favours an even higher level of H 2 O 2 , apoptosis and counteracts tumours. The mechanisms involved will be discussed. 
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The mechanism and regulation of F-ATPases John E Walker Medical Research Council Mitochondrial Biology Unit, Cambridge, UK E-mail: walker@mrcbu.cam.ac.uk More than 25 high-resolution structures of mitochondrial F 1 -ATPase have been determined to date. Comparison of all of the structures with each other, and examination of lattice contacts in the crystals used to solve each structure show that neither the conformations adopted by the catalytic subunits nor the occupancy of those subunits by nucleotides is influenced by lattice contacts. Therefore, the structures interpreted as representing ground and transition states depict the structures of intermediates in the catalytic cycle. In the ground state two of the catalytic sites are attached by nucleotides and the third site is unoccupied, whereas in the transition state, nucleotides occupy all three catalytic sites. Two recent structures, one of yeast F 1 -ATPase inhibited with yeast inhibitor protein, IF 1 , the other of the enzyme crystallized in the presence of phosphonate, appear to represent post-hydrolysis preproduct release intermediates. The current structures occupy about 20°of each of the three 120°steps in a complete 360°catalytic cycle. The lecture will discuss strategies for accessing structures that represent the "missing" part of the catalytic cycle. It will also discuss the different regulatory mechanisms of F-ATPases from mitochondria, chloroplasts and bacteria, by the inhibitor protein, by a redox switch, and possibly by the binding of ATP to the ε-subunit, respectively. Having worked for 55 years in the center and at the fringe of bioenergetics, the major research stations are reviewed in my wanderings from microsomes to mitochondria, from NAD to CoQ, from reversed electron transport to reversed oxidative phosphorylation, from mitochondrial hydrogen transfer to phosphate transfer pathways, from endogenous nucleotides to mitochondrial compartmentation, from transport to mechanism, from carrier to structure, from coupling by AAC to uncoupling by UCP, and from specific to general transport laws. These wanderings are recalled with varying emphasis paid to the covered science stations. Major attention will be Mitochondria-targeted cationic plastoquinone derivatives (SkQs) operate as antioxidants in two quite different ways: (i) directly (by preventing cardiolipin peroxidation) and (ii) indirectly (by fatty acid cycling resulting in mild uncoupling which inhibits ROS formation in State 4). The quinol and cationic moieties of SkQs are involved in cases (i) and (ii), respectively. In case (i) SkQH 2 interrupts propagation of chain reactions involved in peroxidation of unsaturated fatty acids in cardiolipin, the formed SkQ
•− being reduced back to SkQH 2 by heme b H of complex III. Molecular dynamics simulation showed that there are two stable conformations of SkQ1 with the quinol residue localized near peroxyl radicals at C 9 or C 13 of the cardiolipin linoleate residues. In case (ii), fatty acid cycling is involved, which consists of (a) transmembrane movement of the SkQ cation/fatty acid anion pair and (b) back flows of SkQ cation and protonated fatty acid. The cycling results in H + conductance of planar phospholipid membranes and liposomes. In mitochondria, the cycling causes mild uncoupling, thereby decreasing membrane potential and ROS generation coupled to reverse electron transport. In yeast cells, dodecyltriphenylphosphonium (С 12 TPP), the cationic part of SkQ1, induces uncoupling that is mitochondria-targeted since С 12 TPP is specifically accumulated in mitochondria and increases the H + conductance of the mitochondrial inner membrane. The outer cell membrane conductance is not affected by С 12 TPP. In human cell cultures, plastoquinonyl decyltriphenylphosphonium (SkQ1) and its analog, plastoquinonyl decylrhodamine 19 (SkQR1) arrest H 2 O 2 -induced apoptosis. When tested in vivo, SkQs (i) prolong lifespan of fungi, crustaceans, insects, fish, and mice, (ii) suppress appearance of many traits typical for age-related senescence (cataract, retinopathies, achromotrichia, balding, osteoporosis, decline of immune system, myeloid shift of blood cells, activation of apoptosis, induction of β-galactosidase, phosphorylation of H2AX histones, etc.), and (iii) lower tissue damage and save the lives of young animals after treatments resulting in kidney ischemia, rhabdomyolysis, heart attack, heart arrhythmia, and stroke. It is assumed that SkQs interrupt execution of programs responsible for both senescence and fast "biochemical suicide" of organism after a severe metabolic crisis. 
